ALXO

ALX Oncology News

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Basic
Monthly Subscription
for only
$33.03
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
VAT not included
Company Name Stock Ticker Symbol Market Type
ALX Oncology Holdings Inc ALXO NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.01 -0.12% 8.09 17:30:01
Open Price Low Price High Price Close Price Prev Close
8.06 7.81 8.19 8.09 8.10
more quote information »

Recent News

Date Time Source Heading
6/29/202208:00DJNALX Oncology's Evorpacept Gets FDA Designation for Leukemia
6/29/202207:00GLOBEALX Oncology Receives U.S. FDA Orphan Drug Designation for..
6/10/202210:15EDGARSchedule 13g
(sc 13g/a)
6/08/202205:10TRMNH.C. Wainwright Reaffirms Their Buy Rating on ALX Oncology..
6/07/202205:40TRMNStifel Nicolaus Thinks ALX Oncology Holdings’ Stock is Going..
6/03/202207:00GLOBEALX Oncology Announces Evorpacept Clinical Program Updates
6/01/202207:00GLOBEALX Oncology to Participate in the Jefferies 2022 Healthcare..
5/27/202216:59EDGARPost-effective Amendment to Registration Statement (pos Am)
5/16/202206:16TRMNH.C. Wainwright Thinks ALX Oncology Holdings’ Stock is Going..
5/09/202216:18EDGARQuarterly Report (10-q)
5/09/202216:01GLOBEALX Oncology Reports First Quarter 2022 Financial Results..
4/22/202208:28EDGARProxy Statement (definitive) (def 14a)
4/14/202219:54EDGARStatement of Changes in Beneficial Ownership (4)
4/14/202219:50EDGARInitial Statement of Beneficial Ownership (3)
4/12/202208:35EDGARCurrent Report Filing (8-k)
4/12/202207:00GLOBEALX Oncology Appoints Itziar Canamasas, Ph.D., to its Board..
3/25/202217:32SEEKALX Oncology files for $450 mixed shelf offering
3/25/202216:45EDGARSecurities Registration Statement (simplified Form) (s-3)
3/02/202208:00SEEKALX Oncology begins dosing in phase 2/3 trial of evorpacept..
3/02/202207:00GLOBEALX Oncology Announces First Patient Dosed in ASPEN-06, a..
2/28/202216:57EDGARSecurities Registration: Employee Benefit Plan (s-8)
2/28/202207:58EDGARAnnual Report (10-k)
2/28/202207:47EDGARCurrent Report Filing (8-k)
2/28/202207:18SEEKALX Oncology GAAP EPS of -$0.70 misses by $0.08
2/28/202207:00GLOBEALX Oncology Reports Fourth Quarter and Full Year 2021..
2/09/202209:11EDGARStatement of Ownership (sc 13g)
2/07/202208:27EDGARStatement of Changes in Beneficial Ownership (4)
2/04/202209:13EDGARSchedule 13g
2/01/202216:38EDGARStatement of Changes in Beneficial Ownership (4)
1/27/202218:43DJNALX Oncology Gets FDA Orphan Drug Designation for Evorpacept
1/27/202217:51GLOBEALX Oncology Receives U.S. FDA Orphan Drug Designation for..
1/27/202213:50SEEKALX Oncology gastric cancer candidate granted Orphan Drug..
1/10/202206:00GLOBEALX Oncology Provides Corporate Update and Highlights Key..
1/04/202207:00GLOBEALX Oncology to Present at the 40th Annual J.P. Morgan..
12/17/202116:58EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
12/16/202114:31SEEKALX Oncology plunges as director sells shares worth $75M
12/14/202109:00PRNUSDURECT Corporation Expands Board of Directors with..
12/14/202106:16TRMNH.C. Wainwright Reiterates a Buy Rating on ALX Oncology..
12/13/202114:12SEEKALX Oncology under pressure as director sells shares worth..
12/12/202109:00GLOBEALX Oncology Announces Initial Data from ASPEN-02, the..
11/12/202108:42EDGARQuarterly Report (10-q)
11/11/202116:28SEEKALX Oncology EPS misses by $0.14
11/11/202116:05GLOBEALX Oncology Reports Third Quarter 2021 Financial Results..
11/09/202108:29SEEKALX Oncology down 5% following updated phase 1b results for..
11/09/202107:00GLOBEALX Oncology Announces Updated Data from Ongoing Clinical..
11/04/202113:17SEEKALX Oncology falls after releasing evorpacept study data in..
11/04/202109:00GLOBEALX Oncology to Present New Evorpacept Clinical Data in ..
11/02/202109:00GLOBEALX Oncology Announces Upcoming Virtual Investor Conference..
10/21/202107:00GLOBEALX Oncology Announces First Patient Dosed in ASPEN-05, a..
10/20/202119:11EDGARStatement of Changes in Beneficial Ownership (4)


Your Recent History
NASDAQ
ALXO
ALX Oncolo..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.